Colm Burke
Question:991. Deputy Colm Burke asked the Minister for Health the person within the HSE who decides if a product is experimental in respect of the treatment abroad scheme; the criteria that this decision maker uses to decide such and the definitions applied to experimental treatments; if the relevant decision makers have the expertise to review drugs for complex conditions; if the existing reimbursement list is referred to in making reimbursement decisions or whether European Medicines Agency approval is deemed to be the overriding proof of clinical safety; and if he will make a statement on the matter. [37831/22]
View answer